$LCII
LCI INDUSTRIES

2023 Q3 Form 10-Q Financial Statement

#000076374423000067 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $959.3M $1.015B
YoY Change -15.26% -33.95%
Cost Of Revenue $748.4M $796.5M
YoY Change -14.86% -29.33%
Gross Profit $210.9M $218.1M
YoY Change -16.64% -46.68%
Gross Profit Margin 21.99% 21.5%
Selling, General & Admin $165.4M $162.9M
YoY Change -0.07% -14.37%
% of Gross Profit 78.39% 74.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.27M $33.05M
YoY Change 3.17% 3.58%
% of Gross Profit 15.77% 15.15%
Operating Expenses $165.4M $162.9M
YoY Change -0.07% -14.37%
Operating Profit $45.59M $55.17M
YoY Change -47.94% -74.78%
Interest Expense -$10.33M -$10.25M
YoY Change 49.42% 65.55%
% of Operating Profit -22.65% -18.58%
Other Income/Expense, Net
YoY Change
Pretax Income $35.27M $44.93M
YoY Change -56.28% -78.87%
Income Tax $9.378M $11.50M
% Of Pretax Income 26.59% 25.6%
Net Earnings $25.89M $33.43M
YoY Change -57.83% -78.37%
Net Earnings / Revenue 2.7% 3.29%
Basic Earnings Per Share $1.02 $1.32
Diluted Earnings Per Share $1.02 $1.31
COMMON SHARES
Basic Shares Outstanding 25.32M shares 25.30M shares
Diluted Shares Outstanding 25.50M shares 25.44M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.24M $22.09M
YoY Change 33.5% -59.82%
Cash & Equivalents $31.24M $22.09M
Short-Term Investments
Other Short-Term Assets $68.67M $83.66M
YoY Change 3.67% 18.65%
Inventory $791.9M $830.0M
Prepaid Expenses
Receivables $338.8M $299.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.231B $1.235B
YoY Change -18.26% -27.24%
LONG-TERM ASSETS
Property, Plant & Equipment $472.5M $478.9M
YoY Change 0.41% 4.9%
Goodwill $579.9M $584.3M
YoY Change 5.13% 5.31%
Intangibles $462.4M $477.3M
YoY Change -5.54% -6.91%
Long-Term Investments
YoY Change
Other Assets $54.59M $59.50M
YoY Change -2.29% 3.17%
Total Long-Term Assets $1.803B $1.841B
YoY Change 2.25% 3.15%
TOTAL ASSETS
Total Short-Term Assets $1.231B $1.235B
Total Long-Term Assets $1.803B $1.841B
Total Assets $3.034B $3.076B
YoY Change -7.19% -11.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $198.9M $182.6M
YoY Change -1.05% -36.51%
Accrued Expenses $179.9M $196.1M
YoY Change -26.01% -33.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $566.0K $27.71M
YoY Change -97.44% 32.09%
Total Short-Term Liabilities $414.0M $441.5M
YoY Change -17.22% -30.83%
LONG-TERM LIABILITIES
Long-Term Debt $908.2M $915.8M
YoY Change -12.66% -16.88%
Other Long-Term Liabilities $102.8M $103.4M
YoY Change -2.95% -26.18%
Total Long-Term Liabilities $1.011B $1.019B
YoY Change -11.76% -17.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $414.0M $441.5M
Total Long-Term Liabilities $1.011B $1.019B
Total Liabilities $1.662B $1.706B
YoY Change -9.96% -18.33%
SHAREHOLDERS EQUITY
Retained Earnings $1.207B $1.208B
YoY Change -4.65% -1.9%
Common Stock $241.3M $235.8M
YoY Change 4.08% 5.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $82.22M $82.22M
YoY Change 41.36% 41.36%
Treasury Stock Shares
Shareholders Equity $1.372B $1.371B
YoY Change
Total Liabilities & Shareholders Equity $3.034B $3.076B
YoY Change -7.19% -11.67%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $25.89M $33.43M
YoY Change -57.83% -78.37%
Depreciation, Depletion And Amortization $33.27M $33.05M
YoY Change 3.17% 3.58%
Cash From Operating Activities $115.7M $198.9M
YoY Change -15.88% -6.64%
INVESTING ACTIVITIES
Capital Expenditures $15.98M $16.92M
YoY Change -148.55% -158.76%
Acquisitions
YoY Change
Other Investing Activities -$60.00K -$17.22M
YoY Change -98.5% -2481.33%
Cash From Investing Activities -$16.04M -$34.14M
YoY Change -56.53% 21.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -90.13M -166.5M
YoY Change -30.96% -10.04%
NET CHANGE
Cash From Operating Activities 115.7M 198.9M
Cash From Investing Activities -16.04M -34.14M
Cash From Financing Activities -90.13M -166.5M
Net Change In Cash 9.532M -1.746M
YoY Change -131.88% 1547.17%
FREE CASH FLOW
Cash From Operating Activities $115.7M $198.9M
Capital Expenditures $15.98M $16.92M
Free Cash Flow $99.72M $182.0M
YoY Change -41.5% -24.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1381008000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7259000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
119091 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-8888000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4695000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q1 us-gaap Dividends Cash
DividendsCash
26563000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1359511000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
33426000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
26445 shares
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-697000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4385000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
863000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q2 us-gaap Dividends Cash
DividendsCash
26591000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1370897000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to product returns, sales and purchase rebates, accounts receivable, inventories, goodwill and other intangible assets, net assets of acquired businesses, income taxes, warranty and product recall obligations, self-insurance obligations, operating lease right-of-use assets and obligations, asset retirement obligations, long-lived assets, pension and post-retirement benefits, stock-based compensation, segment allocations, contingent consideration, environmental liabilities, contingencies, and litigation. The Company bases its estimates on historical experience, other available information, and various other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities not readily apparent from other resources. Actual results and events could differ significantly from management estimates.</span></div>
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25273000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25377000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
86000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
106000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25359000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25483000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
162000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
111000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2800000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
259.84
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
259.84
CY2021Q2 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
100100000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
567063000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
18314000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-3048000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1983000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
584312000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
758304000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
280997000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
477307000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
759043000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
255723000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
503320000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
503777000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
600601000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
45379000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
44850000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
280864000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
384254000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
830020000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1029705000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
61500000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
55900000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
976047000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
945255000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
497162000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
463070000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
478885000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
482185000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54837000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77804000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
41988000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
35148000 usd
CY2023Q2 lcii Business Combination Deferred Acquisition Payments And Contingent Consideration Liability Current
BusinessCombinationDeferredAcquisitionPaymentsAndContingentConsiderationLiabilityCurrent
33692000 usd
CY2022Q4 lcii Business Combination Deferred Acquisition Payments And Contingent Consideration Liability Current
BusinessCombinationDeferredAcquisitionPaymentsAndContingentConsiderationLiabilityCurrent
34013000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
65582000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
72273000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
196099000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
219238000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
54528000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
52114000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
40128000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
28164000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
2200000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1649000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
18177000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
31968000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
18646000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
62688000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
61632000 usd
CY2023Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20700000 usd
CY2022Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
21460000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
41988000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
40172000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7932000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9052000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
943468000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1118974000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
27712000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
23086000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
915756000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1095888000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15670000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
13236000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
30914000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
26148000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1307000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1934000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
2787000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3774000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1200000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
936000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
16106000 usd
us-gaap Lease Cost
LeaseCost
35901000 usd
us-gaap Lease Cost
LeaseCost
31571000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28665000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28519000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3341000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3341000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25324000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25178000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.90
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
4.05
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.10
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
200000000 shares
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
253490 shares
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
94.89
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24100000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q2 us-gaap Revenues
Revenues
1014639000 usd
CY2022Q2 us-gaap Revenues
Revenues
1536150000 usd
us-gaap Revenues
Revenues
3180718000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
55174000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
218789000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
75217000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
488490000 usd
CY2023Q2 us-gaap Revenues
Revenues
1014639000 usd
CY2022Q2 us-gaap Revenues
Revenues
1536150000 usd
us-gaap Revenues
Revenues
3180718000 usd
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000763744-23-000067-index-headers.html Edgar Link pending
0000763744-23-000067-index.html Edgar Link pending
0000763744-23-000067.txt Edgar Link pending
0000763744-23-000067-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lcii-06302023xex311.htm Edgar Link pending
lcii-06302023xex312.htm Edgar Link pending
lcii-06302023xex321.htm Edgar Link pending
lcii-06302023xex322.htm Edgar Link pending
lcii-20230630.htm Edgar Link pending
lcii-20230630.xsd Edgar Link pending
lcii-20230630_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lcii-20230630_cal.xml Edgar Link unprocessable
lcii-20230630_def.xml Edgar Link unprocessable
lcii-20230630_lab.xml Edgar Link unprocessable
lcii-20230630_pre.xml Edgar Link unprocessable
lcii-20230630_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending